OVIT OTC
OncoVista Innovative Therapies, Inc.
1W: +0.0%
1M: +0.0%
3M: -0.0%
YTD: -75.0%
1Y: +0.0%
3Y: -93.3%
5Y: -99.5%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000099999997-0.0004
Volume5,650
Avg Volume163
Beta-1.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAlexander L. Weis
Employees2
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2007-10-26
Websiteoncovista.com
14785 Omicron Drive
San Antonio, TX 78245
US
San Antonio, TX 78245
US
210-677-6000
About OncoVista Innovative Therapies, Inc.
OncoVista Innovative Therapies, Inc. is a drug development company, which engages in the development and commercialization of targeted cancer therapies. The firm produces drug discovery, registration strategies, and emerging technologies. Its products include Cordycepin and L-Nucleoside Conjugate. The company was founded on January 8, 1999 and is headquartered in San Antonio, TX.
Latest News
No recent news
Recent Insider Trades
No insider trades found